U.K. authorizes Moderna COVID-19 vaccine

By The Science Advisory Board staff writers

January 8, 2021 -- The U.K.'s Medicines and Healthcare products Regulatory Agency approved Moderna's messenger RNA (mRNA) COVID-19 vaccine, mRNA-1273, for use under Regulation 174.

The temporary authorization permits the supply of the COVID-19 vaccine in Great Britain. The U.K. government purchased an additional 10 million doses of the Moderna vaccine, bringing its confirmed order commitment to 17 million doses. The first U.K. deliveries of the vaccine will commence early this year, Moderna said.

The U.K. is the fifth jurisdiction to authorize Moderna's COVID-19 vaccine, following the U.S., Canada, Israel, and the European Union. Additional authorizations are currently under review in a number of countries such as Singapore and Switzerland, the firm said.


Copyright © 2021 scienceboard.net
 
To access all The ScienceBoard content create a free account now:


Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.


Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Already have an account? Sign in here